Microbiome Congress 2019 | Kisaco Research

European Microbiome Congress

Modulating the gut microbiota to create clinically viable treatments for neurological, cancer and metabolic diseases

Download Agenda

EUROPEAN MICROBIOME CONGRESS

London, UK
13-14 November, 2019

“It was fascinating seeing academic science morph into products/drugs that have clinical application. Plus, the networking was fantastic. ”

Associate Professor, University of Maryland School of Nursing

Why Attend

The gut microbiota’s importance in human health and disease progression spreads far wider than just gastro-intestinal conditions. The immune, nervous and metabolic systems couple the microbiome with the rest of the body and play a crucial and interlinking role in extra-intestinal diseases including neurological, cancer and metabolic conditions.

For the 5th annual European Microbiome Congress, we’ve shifted the focus from gastro-intestinal to extra-intestinal as we examine the latest pre-clinical and clinical data demonstrating the gut microbiota’s role in some of the world’s most critical and costly diseases in modern society.

Join key opinion leaders from across academia and industry to examine the latest research data. This is your opportunity to find outhow others plan to translate the latest understanding of the gut-microbiome into therapeutic drugs that have the power to treat
cancer, metabolic, neurodegenerative and psychiatric disorders.

Submit your poster

Looking to showcase your recent work to the microbiome community?

Our dedicated poster area is the perfect way to get your research noticed and further involve yourself in the congress. In order to present a poster at the forum you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first come first served basis (subject to checks and successful registration).

At the Congress, your presentation will be displayed in a dedicated poster area which can be viewed during the networking break.

CLICK HERE TO MAKE A SUBMISSION

200+
Delegates
50:50
Ratio of Academics - Industry
5+
Microbiome Niches Covered
50+
Leading Top Speakers
10
Hours of Dedicated Networking

Series Highlights

European Microbiome Congress, 2016

Who Will Be There

50%
Academics
20%
Biotech
20%
Pharma & Food Companies
10%
Investors

Academics

Biotech

Pharma & Food Companies

Investors

Speakers

 

Adrien Nivoliez

CEO
Biose

Adrien Nivoliez

CEO
Biose

Adrien Nivoliez

CEO
Biose
 

Aletta Kraneveld

Professor of Pharmacology
Utrecht University

Aletta Kraneveld studied Pharmacy at the schools of Pharmacy at University of Amsterdam and Utrecht University. As a junior researcher she worked at the department of Gastrointestinal Pharmacology of Glaxo Group Research in the UK (1990-1991). She obtained her PhD at the department of Pharmacology, Faculty of Pharmacy, Utrecht University (1994) after which she did an internship at the department of Pathology, Harvard Medical School Boston MA, USA (PI Steve Galli). As a post doc she continued her research as immune-pharmacologist in Utrecht.

Aletta Kraneveld

Professor of Pharmacology
Utrecht University

Aletta Kraneveld

Professor of Pharmacology
Utrecht University

Aletta Kraneveld studied Pharmacy at the schools of Pharmacy at University of Amsterdam and Utrecht University. As a junior researcher she worked at the department of Gastrointestinal Pharmacology of Glaxo Group Research in the UK (1990-1991). She obtained her PhD at the department of Pharmacology, Faculty of Pharmacy, Utrecht University (1994) after which she did an internship at the department of Pathology, Harvard Medical School Boston MA, USA (PI Steve Galli). As a post doc she continued her research as immune-pharmacologist in Utrecht. In 1998 Aletta was appointed as assistant professor and in 2002 as associate professor at the division of Pharmacology of the department of Pharmaceutical Sciences of the Utrecht University. She has published 80 papers (H-index: 30). Besides science, she is an active member of several boards of (inter)national scientific organizations (Dutch Society of Pharmacology, EPHAR, IUPHAR, Netherlands Federation of Innovative Drug research).. 

 

Andrew Morgan

DuPont Fellow & Chief Scientist
Dupont Nutrition & Health

Dr Andrew Morgan, DuPont Fellow and Chief Scientist, DuPont Nutrition & Health Over 35 years’ experience in research and development including  human health & nutrition, animal nutrition, industrial enzymes and crop science as well as innovation management, business development and corporate venturing including founding member of DuPont Nutrition & Health’s Microbiome Venture

Andrew Morgan

DuPont Fellow & Chief Scientist
Dupont Nutrition & Health

Andrew Morgan

DuPont Fellow & Chief Scientist
Dupont Nutrition & Health

Dr Andrew Morgan, DuPont Fellow and Chief Scientist, DuPont Nutrition & Health Over 35 years’ experience in research and development including  human health & nutrition, animal nutrition, industrial enzymes and crop science as well as innovation management, business development and corporate venturing including founding member of DuPont Nutrition & Health’s Microbiome Venture

 

Anna Ettore

Senior Immunologist Team Leader
4D Pharma

Anna Ettore

Senior Immunologist Team Leader
4D Pharma

Anna Ettore

Senior Immunologist Team Leader
4D Pharma
 

Dr. Sabine Hazan

Founder/CEO
ProgenaBiome, Ventura Clinical Trials

Dr. Sabine Hazan, acclaimed Gastroenterologist and founder of ProgenaBiome, LLC, Ventura Clinical Trials, LLC, and Malibu Specialty Center, is at the forefront of medicine. She recently turned her focus from doing Fecal Microbiota Transplant, also known as FMT to better understand the microbiome. FMT is the process of recolonizing the gut with good flora in hopes to cure specific disease. Spearheading advancement in medicine, this treatment is being explored by Dr. Hazan following the leadership of Dr. Thomas Borody and the late Dr.

Dr. Sabine Hazan

Founder/CEO
ProgenaBiome, Ventura Clinical Trials

Dr. Sabine Hazan

Founder/CEO
ProgenaBiome, Ventura Clinical Trials

Dr. Sabine Hazan, acclaimed Gastroenterologist and founder of ProgenaBiome, LLC, Ventura Clinical Trials, LLC, and Malibu Specialty Center, is at the forefront of medicine. She recently turned her focus from doing Fecal Microbiota Transplant, also known as FMT to better understand the microbiome. FMT is the process of recolonizing the gut with good flora in hopes to cure specific disease. Spearheading advancement in medicine, this treatment is being explored by Dr. Hazan following the leadership of Dr. Thomas Borody and the late Dr. Sydney Finegold to treat Crohn’s disease, Celiac disease, Alzheimer’s disease, Alopecia areata, Autism, Obesity, Metastatic cancer, and recurrent infection with Clostridium difficile.  She is a firm believer in the potential to recolonize your gut back to health recognizing that much work is still left to be done.

Well-prepared for these endeavors, Dr. Hazan was the first woman accepted in to the University of Florida as a Clinical Gastroenterology Fellow, and has continued to be a pioneer in medicine. She has over 22 years of experience in clinical trials and has also been published in numerous medical journals. In the past year, she has served as the series editor for the journal Practical Gastroenterology, for a series on the microbiome. As a trailblazer from the start, she believes in using logic when practicing medicine and tries to think outside the box. “I always remind myself that much like every fingerprint is different, every patient’s symptom is different, and one cannot practice like a robot.”

 

Ben Mullish

Cinical Research Fellow, Dept. of Metabolism, Digestion and Reproduction
Imperial College London

Ben Mullish

Cinical Research Fellow, Dept. of Metabolism, Digestion and Reproduction
Imperial College London

Ben Mullish

Cinical Research Fellow, Dept. of Metabolism, Digestion and Reproduction
Imperial College London
 

Benno Haarman

Head of Program, Mood and Anxiety Disorders
University of Groningen

Benno Haarman

Head of Program, Mood and Anxiety Disorders
University of Groningen

Benno Haarman

Head of Program, Mood and Anxiety Disorders
University of Groningen
 

Benoit Lavast

Preclinical Scientist
Maat Pharma

Benoit Lavast

Preclinical Scientist
Maat Pharma

Benoit Lavast

Preclinical Scientist
Maat Pharma
 

Christopher Reyes

Co-Founder & CEO
Bloom Science

Christopher Reyes

Co-Founder & CEO
Bloom Science

Christopher Reyes

Co-Founder & CEO
Bloom Science
 

Georg Zeller

Team Leader, Structural & Computational Biology
European Molecular Biology Laboratory

Georg Zeller

Team Leader, Structural & Computational Biology
European Molecular Biology Laboratory

Georg Zeller

Team Leader, Structural & Computational Biology
European Molecular Biology Laboratory
 

Grégory Lambert

CEO & VP, R&D
TargEDys SA

Grégory Lambert’s career has been split between biotech and pharma as VP of R&D and CSO in companies such as Novagali Pharma (now Santen) and Septodont. His responsibilities have included innovation, CMC, pre-clinical and clinical development in both Europe and North America.

Grégory Lambert

CEO & VP, R&D
TargEDys SA

Grégory Lambert

CEO & VP, R&D
TargEDys SA

Grégory Lambert’s career has been split between biotech and pharma as VP of R&D and CSO in companies such as Novagali Pharma (now Santen) and Septodont. His responsibilities have included innovation, CMC, pre-clinical and clinical development in both Europe and North America. Grégory also has experience managing IP, business development and general management.  He is an inventor on more than 20 patents, he was involved in the IPO of Novagali Pharma and he has driven the development of several pharmaceutical products from the laboratory through to market authorisation. In 2014, Gregory joined the scientific founders of TargEDys as CEO to setup the business plan and start operations, so far has raised over 10M€ in a mixture of grant and VC funding and begins human clinical trials this year.

 

Imke Mulder

Research Director
4D Pharma

Imke Mulder

Research Director
4D Pharma

Imke Mulder

Research Director
4D Pharma
 

Isablle de Cremoux

CEO
Seventure

Isablle de Cremoux

CEO
Seventure

Isablle de Cremoux

CEO
Seventure
 

Dr James Kinross

Senior Lecturer in Colorectal Surgery
Imperial College London

Dr. James Kinross is a consultant colorectal surgeon, at St. Mary’s Hospital London. His clinical interests are in minimally invasive and laparoscopic surgery for the treatment of colorectal cancer. He also has an interest in surgical nutrition and modulation of the gut microbiota by pro and prebiotics for improved operative outcomes. He was trained in Northwest London, and he was an NIHR Clinical Lecturer in Surgery and an Ethicon Laparoscopic Fellow in Colorectal Surgery.

Dr James Kinross

Senior Lecturer in Colorectal Surgery
Imperial College London

Dr James Kinross

Senior Lecturer in Colorectal Surgery
Imperial College London

Dr. James Kinross is a consultant colorectal surgeon, at St. Mary’s Hospital London. His clinical interests are in minimally invasive and laparoscopic surgery for the treatment of colorectal cancer. He also has an interest in surgical nutrition and modulation of the gut microbiota by pro and prebiotics for improved operative outcomes. He was trained in Northwest London, and he was an NIHR Clinical Lecturer in Surgery and an Ethicon Laparoscopic Fellow in Colorectal Surgery. He was awarded a Royal College of Surgeons of England training fellowship during his PhD and he was funded by the Academy of Medical Sciences as an early stage lecturer. He is a visiting Professor at the Royal College of Surgeons of Ireland. He is currently funded by Bowel and Cancer research and the Imperial BRC.

 

James McIlroy

Founder
EnteroBiotix

James McIlroy

Founder
EnteroBiotix

James McIlroy

Founder
EnteroBiotix
 

Johan Garrsen

Director/Professor
Danone Nutricia Research/Utrecht University

Johan Garrsen

Director/Professor
Danone Nutricia Research/Utrecht University

Johan Garrsen

Director/Professor
Danone Nutricia Research/Utrecht University
 

Jos Seegers

Operational Manager
Caelus

Jos Seegers

Operational Manager
Caelus

Jos Seegers

Operational Manager
Caelus
 

Karine Clement

Professor of Nutrition
INSERM/Sorbonne University

Karine Clement

Professor of Nutrition
INSERM/Sorbonne University

Karine Clement

Professor of Nutrition
INSERM/Sorbonne University
 

Laura Steenbergen

Assistant Professor
University of Leiden

Laura Steenbergen

Assistant Professor
University of Leiden

Laura Steenbergen

Assistant Professor
University of Leiden
 

Morten Isaksen

CEO
Bio-Me

Morten Isaksen

CEO
Bio-Me

Morten Isaksen

CEO
Bio-Me
 

Nader Yaghoubi

Co-founder & CEO
Symbiotix Biotherapies

Nader Yaghoubi

Co-founder & CEO
Symbiotix Biotherapies

Nader Yaghoubi

Co-founder & CEO
Symbiotix Biotherapies
 

Patrice Garnier

CEO
Amabiotics

Patrice Garnier

CEO
Amabiotics

Patrice Garnier

CEO
Amabiotics
 

Paul Wilmes

Assistant professeur
Luxembourg Centre for Systems Biomedicine, University of Luxembourg

Paul Wilmes

Assistant professeur
Luxembourg Centre for Systems Biomedicine, University of Luxembourg

Paul Wilmes

Assistant professeur
Luxembourg Centre for Systems Biomedicine, University of Luxembourg
 

Robert Jan Brummer

Professor
Orebro University

Robert Jan Brummer

Professor
Orebro University

Robert Jan Brummer

Professor
Orebro University
 

Rochellys Diaz Heijz

Associate Professor
Karolinska Institute

Rochellys Diaz Heijz

Associate Professor
Karolinska Institute

Rochellys Diaz Heijz

Associate Professor
Karolinska Institute
 

Arne Materna Ph.D

Vice President Products
Cosmos ID

Arne Materna Ph.D

Vice President Products
Cosmos ID

Arne Materna Ph.D

Vice President Products
Cosmos ID
 

Shahram Lavasani

Founder & CEO
ImmuneBiotech

Shahram Lavasani

Founder & CEO
ImmuneBiotech

Shahram Lavasani

Founder & CEO
ImmuneBiotech
 

Yolanda Sanz Herranz

Senior Researcher
IARA-CSIC

Yolanda Sanz Herranz

Senior Researcher
IARA-CSIC

Yolanda Sanz Herranz

Senior Researcher
IARA-CSIC

Associate Event Partner

Thought Leadership Partner

Event Partners

Media Partners

Become a Sponsor

Kisaco Research provides the much needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at partner@kisacoresearch.com.

The Agenda

We're excited to share that the agenda for the 5th annual European Microbiome Congress is now live. To find out what you can expect onsite, please download the agenda.

NEW FOR 2019:

The gut microbiota has been proven to be a viable drug target for gastro-intestinal diseases such as IBD, Crohns and Colitis - however, there is growing (pre)clinical data to translate findings from the gut microbiome to extra-intestinal conditions. This year, we will explore beyond the gut and focus on 3 major topics:
  • Gut-brain axis
  • Microbiome-oncology
  • Microbiome and metabolic diseases

Download Agenda

Venue

Olympia London, Hammersmith Rd, London W14 8UX

Hilton London Olympia, 380 Kensington High Street, London W14 8NL  (0.2miles from the Olympia Conference Centre)

Rate: £215 includes VAT including English breakfast, single occupancy

Book online: http://eventsathilton.com/show/5cacc48e2322ec7c5fd65560

Book by 13th October 2019.

 

The Copthorne Tara Hotel, Scarsdale Place, London, W8 5SR (1.0mile from Olympia Conference Centre)

Rate per night:  £130 includes VAT and breakfast, single occupancy

Call reservations  + 44 (0) 207 872 2000

Email:[email protected]

Quote code GA1L121119 when booking

Book by 15th October 2019.

 

Ibis Earl’s Court Hotel, 47 Lillie Road, Fulham, London, SW6 1UD (1.0mile from the Olympia Conference Centre)

Rate: £99 includes VAT and breakfast, single occupancy

Email: Email Enrico in reservations on [email protected] 

Phone: Enrico on +44(0) 207 666 8495

Quote booking code KISACO121119-1 when booking.

Book by 15th October 2019.

 

Millennium Gloucester Hotel, 4-18 Harrington Gardens, South Kensington, London, SW7 4LH (1.5miles from the Olympia Conference Centre)

Rate per night: £170 includes vat and breakfast, single occupancy

Book online: https://www.millenniumhotels.com/en/london/millennium-gloucester-hotel-london-kensington/

Select dates, click on advanced search and add the code KISA12119 in the promo box.

Call reservations on +44(0) 207 331 6195

Email: [email protected]

Quote code KISA12119 when booking.

Book by 8th October 2019.

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Worldpay:

Ticket prices increase in

Friday, December 21, 2018 to Friday, September 6, 2019
Academics, Clinicians & Start-ups
£699 + VAT
Super Early Bird - book before 6 September
2-Day Main Conference
Post-Show Access to Presentations
Welcome Networking Reception
Complimentary Articles and Content
Daily Lunches & Refreshments
Friday, December 21, 2018 to Friday, September 6, 2019
Pharmaceutical, Nutrition and Biotech
£1,299 + VAT
Super Early Bird - book before 11 October
Must have an active drug pipeline
2-Day Main Conference
Post-Show Access to Presentations
Welcome Networking Reception
Complimentary Articles and Content
Daily Lunches & Refreshments
Friday, December 21, 2018 to Friday, September 6, 2019
Service Providers, Vendors
£1,599 + VAT
Super Early Bird - book before 6 September
2-Day Main Conference
Post-Show Access to Presentations
Welcome Networking Reception
Complimentary Articles and Content
Daily Lunches & Refreshments
Preparing registration...

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.